Peter Higgins

26.3k total citations · 8 hit papers
331 papers, 15.5k citations indexed

About

Peter Higgins is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Peter Higgins has authored 331 papers receiving a total of 15.5k indexed citations (citations by other indexed papers that have themselves been cited), including 202 papers in Genetics, 162 papers in Epidemiology and 107 papers in Surgery. Recurrent topics in Peter Higgins's work include Inflammatory Bowel Disease (196 papers), Microscopic Colitis (126 papers) and Helicobacter pylori-related gastroenterology studies (29 papers). Peter Higgins is often cited by papers focused on Inflammatory Bowel Disease (196 papers), Microscopic Colitis (126 papers) and Helicobacter pylori-related gastroenterology studies (29 papers). Peter Higgins collaborates with scholars based in United States, United Kingdom and Canada. Peter Higgins's co-authors include Akbar K. Waljee, Ryan W. Stidham, Amit G. Singal, Stephen B. Gruber, Laura A. Johnson, Maneesh Dave, Shail M. Govani, Marie‐France Demierre, Ernest T. Hawk and Scott M. Lippman and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Peter Higgins

317 papers receiving 15.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

2012 1.2k citations Wolfgang Hueber, Bruce E. Sands et al. Gut profile →
Statins and cancer prevention

2005 647 citations Peter Higgins et al. profile →
Statins and the Risk of Colorectal Cancer

2005 612 citations Peter Higgins et al. profile →
A Primer on Effectiveness and Efficacy Trials

2014 441 citations Peter Higgins, Akbar K. Waljee et al. profile →
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials

2017 296 citations Stefan Schreiber, Bruce E. Sands et al. Gut profile →
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies

2015 284 citations Peter Higgins et al. profile →
Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis

2020 207 citations Stefan Schreiber, Wen Zhou et al. profile →
Management of Crohn Disease

2021 197 citations Kelly C. Cushing, Peter Higgins profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Peter Higgins	6.3k	5.0k	4.6k	2.4k	2.3k	331	15.5k
Siddharth Singh	6.9k 1.1×	11.1k 2.2×	6.2k 1.3×	1.7k 0.7×	1.9k 0.8×	412	20.9k
Jochen Hampe	4.7k 0.7×	3.8k 0.8×	3.5k 0.8×	3.2k 1.3×	1.5k 0.6×	285	13.3k
Axel Dignaß	10.1k 1.6×	7.1k 1.4×	5.1k 1.1×	2.7k 1.1×	1.5k 0.7×	282	17.3k
Jerome I. Rotter	8.3k 1.3×	3.8k 0.8×	5.5k 1.2×	3.4k 1.4×	827 0.4×	494	22.0k
David T. Rubin	11.1k 1.8×	8.5k 1.7×	5.1k 1.1×	2.3k 1.0×	2.2k 1.0×	727	18.1k
Marc Ferrante	12.4k 2.0×	8.9k 1.8×	5.3k 1.1×	4.7k 2.0×	3.1k 1.4×	543	21.4k
Lars Pedersen	1.8k 0.3×	3.6k 0.7×	5.8k 1.2×	1.3k 0.5×	2.6k 1.1×	353	22.8k
Julián Panés	14.2k 2.3×	11.2k 2.2×	8.5k 1.8×	4.8k 2.0×	2.7k 1.2×	590	26.0k
Toshifumi Hibi∥	9.9k 1.6×	8.3k 1.7×	7.6k 1.6×	7.1k 3.0×	2.8k 1.2×	788	26.6k
Rami Eliakim	6.9k 1.1×	5.4k 1.1×	5.8k 1.2×	2.1k 0.9×	1.6k 0.7×	322	14.5k

Countries citing papers authored by Peter Higgins

Since Specialization

Citations

This map shows the geographic impact of Peter Higgins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Higgins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Higgins more than expected).

Fields of papers citing papers by Peter Higgins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Higgins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Higgins. The network helps show where Peter Higgins may publish in the future.

Co-authorship network of co-authors of Peter Higgins

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Higgins. A scholar is included among the top collaborators of Peter Higgins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Higgins. Peter Higgins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Higgins, Peter, et al.. (2025). Disseminated Chickenpox Following Live Varicella Vaccination in a Crohn’s Disease Patient on Combination Immunosuppression. Case Reports in Gastrointestinal Medicine. 2025(1). 6088333–6088333.

Berinstein, Jeffrey, Kira L. Newman, Sarah T. Hawley, et al.. (2025). Reddit as a Social Media Self-Management Tool for Inflammatory Bowel Disease: Qualitative Analysis. Journal of Medical Internet Research. 27. e75137–e75137. 1 indexed citations

Koleck, Theresa A., et al.. (2025). AOUSDOHtools: An R Package for Social Determinants of Health Survey data in the All of Us Research Program. The Journal of Open Source Software. 10(116). 9306–9306.

Barnes, Edward L., Laura E. Raffals, Taha Qazi, et al.. (2025). A Prospective Comparison of Ustekinumab and Antitumor Necrosis Factor α Therapy in the Treatment of Crohn's-Like Disease of the Pouch. The American Journal of Gastroenterology.

Long, Millie D., Stefan Schreiber, Toshifumi Hibi∥, et al.. (2024). Association of Bowel Urgency With Quality-of-Life Measures in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From Phase 3 LUCENT-1 (Induction) and LUCENT-2 (Maintenance) Studies. Crohn s & Colitis 360. 6(1). otae001–otae001. 4 indexed citations

Kayal, Maia, Elizabeth A. Spencer, Matthew D. Smyth, et al.. (2024). Risankizumab Is Effective for The Management of Crohn’s Disease of the Pouch. Inflammatory Bowel Diseases. 31(3). 878–881. 1 indexed citations

Noureldin, Mohamed, Kira L. Newman, Peter Higgins, et al.. (2023). Profiles of Web-based Portal Users with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 30(1). 83–89. 1 indexed citations

Cushing, Kelly C., Yanhua Chen, Xiaomeng Du, et al.. (2023). Risk Variants in or NearZBTB40ANDNFATC1Increase the Risk of Both IBD and Adverse Bone Health Outcomes Highlighting Common Genetic Underpinnings Across Both Diseases. Inflammatory Bowel Diseases. 29(6). 938–945. 2 indexed citations

Golob, Jonathan L., Krishna Rao, Jeffrey Berinstein, et al.. (2023). The Microbiome in Quiescent Crohn’s Disease With Persistent Symptoms Show Disruptions in Microbial Sulfur and Tryptophan Pathways. SHILAP Revista de lepidopterología. 3(2). 167–177. 2 indexed citations

10.

Barnes, Edward L., Poonam Beniwal‐Patel, Parakkal Deepak, et al.. (2023). Dietary Patterns Are Not Associated With Disease Activity Among Patients With Inflammatory Conditions of the Pouch in a Prospective Cohort. Crohn s & Colitis 360. 5(3). otad039–otad039. 1 indexed citations

11.

Kayal, Maia, Parakkal Deepak, Poonam Beniwal‐Patel, et al.. (2023). Changes in Therapy Are Not Associated With Increased Remission in Patients With Crohn's Disease of the Pouch. The American Journal of Gastroenterology. 119(3). 584–587. 4 indexed citations

12.

Cushing, Kelly C., Jóhann E. Guðjónsson, Elizabeth K. Speliotes, & Peter Higgins. (2023). An Assessment of Comparative Medication Durability in Inflammatory Bowel Disease Patients With and Without Co-morbid Psoriasis, Rheumatoid Arthritis, and/or Enteropathic Arthritis. Digestive Diseases and Sciences. 68(10). 4001–4008. 1 indexed citations

13.

Panaccione, Remo, Silvio Danese, Wen Zhou, et al.. (2023). Efficacy and safety of upadacitinib for 16‐week extended induction and 52‐week maintenance therapy in patients with moderately to severely active ulcerative colitis. Alimentary Pharmacology & Therapeutics. 59(3). 393–408. 16 indexed citations

14.

Barnes, Edward L., Parakkal Deepak, Poonam Beniwal‐Patel, et al.. (2022). Treatment Patterns and Standardized Outcome Assessments Among Patients With Inflammatory Conditions of the Pouch in a Prospective Multicenter Registry. Crohn s & Colitis 360. 4(3). otac030–otac030. 9 indexed citations

15.

Steiner, Calen A., Jeffrey Berinstein, Jeremy Louissaint, et al.. (2021). Biomarkers for the Prediction and Diagnosis of Fibrostenosing Crohn’s Disease: A Systematic Review. Clinical Gastroenterology and Hepatology. 20(4). 817–846.e10. 40 indexed citations

16.

Weaver, Kimberly N., Xian Zhang, Xiangfeng Dai, et al.. (2021). Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID. Inflammatory Bowel Diseases. 28(10). 1497–1505. 63 indexed citations

17.

Nagao‐Kitamoto, Hiroko, Jhansi L. Leslie, Sho Kitamoto, et al.. (2020). Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota. Nature Medicine. 26(4). 608–617. 164 indexed citations

18.

Berinstein, Jeffrey, Calen A. Steiner, Randolph E. Regal, et al.. (2018). Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 17(5). 988–990.e1. 68 indexed citations

19.

Higgins, Peter, Peter W. Macfarlane, Jesse Dawson, et al.. (2013). Noninvasive Cardiac Event Monitoring to Detect Atrial Fibrillation After Ischemic Stroke. Stroke. 44(9). 2525–2531. 84 indexed citations

20.

Hueber, Wolfgang, Bruce E. Sands, Steve Lewitzky, et al.. (2012). Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut. 61(12). 1693–1700. 1156 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact